SEC Scores Early Win In Mass. Biotech CEO Fraud Suit

By Reenat Sinay · December 6, 2019, 2:40 PM EST

A Massachusetts federal judge has awarded the U.S. Securities and Exchange Commission an early victory in its suit against two biotech companies and former CEO Patrick Muraca over his misappropriation of investor...

To view the full article, register now.

Documents

Case Information

Case Title

United States Securities and Exchange Commission v. Muraca et al

Case Number

1:17-cv-11400

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

July 31, 2017